Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-445-0 | CAS number: 106-94-5
Endpoint summary
Administrative data
Description of key information
Three studies are available for the acute oral toxicity endpoint:
Clauzeau. J (1993) - LD50 (rat): >2000 mg/kg bw
Paster. Z (1978a) - LD50 (rat): 4260 mg/kg bw
Paster. Z (1978b) - LD50 (rabbit): 540 mg/kg bw
Three studies are available for the acute inhalation toxicity endpoint:
Schorsch. F (1997) - 4h-LC50 (rat): 35000 mg/m^3
Moon. Y.H. et al (1998) - 4h-LC50 (rat): 14374 ppm
Labbé. R (1997a) - 6h-LC50 (rat): between 25 and 35 mg/L
Two studies are available for the acute dermal toxicity endpoint:
de Jouffrey. S (1995a) - LD50 (rat): >2000 mg/kg bw
Paster. Z (1979) - LD50 (rabbit): >10 mL/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 35 000 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Key values have been selected from suitable available studies (i.e. use of recognised species for a given endpoint, recognised exposure time), together with a worst case approach.
Key studies for inhalation have been selected for both systemic toxicity and local effects. The systemic toxicity via inhalation value is taken from the Moon et al (1998) study in which effects seen at the lowest treatment group (10909ppm) consisted of slow reactions and ataxia observed in some animals. These results were considered to represent a NOAEC value as no mortality or other signs of systemic toxicity were observed at this concentration.
The local effects via inhalation NOAEC value is taken from the Schorsch (1997) study in which inflammation of the lung parenchyma which was characterised by pulmonary emphysema and oedema was observed in all test groups, and caused mortalities in test groups above 30.2g/m3. The lowest test group (30.2g/m3) was therefore identified as the NOAEC concentration as local effects did not cause mortalities.
Justification for classification or non-classification
Based upon the high LD50 and LC50 values for oral, dermal and inhalation exposure, and the absence of other major significant effects, the test substance does not need to be classified for acute toxicity according to Directive 67/548/EEC or Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
